Home > 2004 National Report to the EMCDDA by the Reitox National Focal Point. Ireland. New developments, trends and in-depth information on selected issues

Health Research Board. Drugs Misuse Research Division. (2004) 2004 National Report to the EMCDDA by the Reitox National Focal Point. Ireland. New developments, trends and in-depth information on selected issues. Dublin: Health Research Board.

[img]
Preview
PDF (National Report 2004)
726kB

Commissioned each year by the EMCCDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCCDA and are an important resource, among others, for the compilation of its Annual report

Table of contents -
Summary
New developments and trends
Selected issues
• Buprenorphine:
• Alternatives to prison
• Public Nuisance
Bibliography, annexes


Date:2004
Pages:133 p.
Publisher:Health Research Board
Corporate Creators:Health Research Board. Drugs Misuse Research Division
Place of Publication:Dublin
EndNote:View
Accession Number:HRB 2839 (Electronic Only)
Related URLs:
Subjects:A Substance use, abuse, and dependence > Prevalence
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
MM-MO Crime and law > Crime > Substance related crime
MM-MO Crime and law > Crime prevention
MM-MO Crime and law > Justice system > Correctional system and facility
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page